Cumberland Pharmaceuticals
(NASDAQ) CPIX
Cumberland Pharmaceuticals Financials at a Glance
Market Cap
$48.46M
Revenue (TTM)
$44.52M
Net Income (TTM)
$2.84M
EPS (TTM)
$-0.19
P/E Ratio
-16.94
Dividend
$0.00
Beta (Volatility)
0.48 (Low)
Dividend
$0.00
Beta (Volatility)
0.48 (Low)
Price
$3.25
Volume
572
Open
$3.24
Price
$3.25
Volume
572
Open
$3.24
Previous Close
$3.25
Daily Range
$3.16 - $3.30
52-Week Range
$1.85 - $6.26
Dividend
$0.00
Beta (Volatility)
0.48 (Low)
Price
$3.25
Volume
572
Open
$3.24
Previous Close
$3.25
Daily Range
$3.16 - $3.30
52-Week Range
$1.85 - $6.26
CPIX News
CPIX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Cumberland Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareEmployees
93
CEO
A. J. Kazimi, MBA
Website
www.cumberlandpharma.comHeadquarters
Nashville, TN 37203, US
CPIX Financials
Key Financial Metrics (TTM)
Gross Margin
85%
Operating Margin
-6%
Net Income Margin
-6%
Return on Equity
-12%
Return on Capital
-7%
Return on Assets
-4%
Earnings Yield
-5.90%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$48.46M
Shares Outstanding
14.96M
Volume
572
Short Interest
0.00%
Avg. Volume
172.07K
Financials (TTM)
Gross Profit
$37.85M
Operating Income
$2.79M
EBITDA
$2.49M
Operating Cash Flow
$4.93M
Capital Expenditure
$97.90K
Free Cash Flow
$4.83M
Cash & ST Invst.
$11.44M
Total Debt
$10.18M
Cumberland Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$13.68M
+31.1%
Gross Profit
$11.44M
+35.2%
Gross Margin
83.61%
N/A
Market Cap
$48.46M
N/A
Market Cap/Employee
$532.52K
N/A
Employees
91
N/A
Net Income
$1.41M
+25.8%
EBITDA
$47.84K
+3.5%
Quarterly Fundamentals
Net Cash
$1.26M
+148.5%
Accounts Receivable
$16.94M
+44.8%
Inventory
$6.23M
+55.6%
Long Term Debt
$9.71M
-35.7%
Short Term Debt
$467.77K
-91.4%
Return on Assets
-3.69%
N/A
Return on Invested Capital
-6.97%
N/A
Free Cash Flow
$3.03K
-99.8%
Operating Cash Flow
$3.02K
-99.8%